1Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST segment elevation[J]. Eur Heart J,2002,23(23): 1801-1840.
2White HD, Wong CK. Risk stratification and treatment benefits in patients with non ST elevation acute coronary syndromes[ J]. Eur Heart J,2002,23(3): 187-191.
3Harrington RA, Magnus Ohman E. Early invasive strategy for ACS without persistent ST segment elevation: has the time come for drive through angiography? [J] .Eur Heart J,2002,23(3):191-194.
4Gershliek AH.ACS: optimizing the therapeutic options[J].Eur Heart J,2002,23(3): 194-197.
5Morrow DA, Autman EM, Snapinn SM, et al. An integrated clinical approach to predicting the benefit of tirofiban in non ST elevation acute coronary syndromes [ J ]. Eur Heart J, 2002,23 ( 3 ): 223-229.
6Spacek R, Widimsky P, Straka Z, et al. Value of first day angiography /angioplasty in evolving NSTEMI: an open multicenter randomized trial [J] .Eur Heart J,2002,23(3):230-238.
8Ronner E, Boersma E, Akkerhuis KM, et al. Patients with ACS without persitent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein P Ⅱ b/Ⅲ a receptor blocker[J] .Eur Heart J,2002,23(3):239-246.
9Maseri A, Cianflone D.Inflammation in acute coronary syndromes[J].Eur Heart J, 2002,4 (supplements B ) ): 8-13.
10ajahalme SK, Smith DE, Cooper JV, et al. Comparison of patients with ACS with and without systemic hypertension [ J ]. Am J of Cardiol,2003,92(3) :258-263.
7Heintzen MP, HeidlandU, Strauer BE. Management of patients with acute coronary syndrome:should we rely on cardiac marker? [J ]. J Interven Cardiol, 2000,13: 447 ～ 452
8Adams JE Brd, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury: is MB creative kinase the choice for the 1990s? [J].Circulation, 1993,88 (2): 750 ～ 763
9Christenson RH , Duh SH, Sanhai WR, et al. Characteristics of an albumin Cobalt binding test for assessment of acute coronary Syndrome patients: a multicenter Study[J]. Clin Chem, 2001,47: 464 ～ 470
10Newby LK, Storrow AB, Gibler WB, et al. Bedside multimarker testing for risk stratification in chest pain units: the chest pain evaluation by creatine Kinase-MB, myoglobin and troponin Ⅰ study[J ]. Circulation,2001,103(14): 1 832～1 837
